- Chimerix press release (NASDAQ:CMRX): Q3 GAAP EPS of $2.75 beats by $0.65.
- Revenue of $32.56M (+32460.0% Y/Y).
- “Having executed an intentional strategy to narrow the focus of the company on oncology therapies most likely to have profound impact on patients and create the greatest value for shareholders, we are pleased with our strong execution and progress in the third quarter,” said Mike Sherman, Chief Executive Officer of Chimerix.
Chimerix GAAP EPS of $2.75 beats by $0.65, revenue of $32.56M
Recommended For You
More Trending News
About CMRX Stock
Related Stocks
Symbol | Last Price | % Chg |
---|---|---|
CMRX | - | - |
Chimerix, Inc. |